Synopsis
Last month, rating agency Care upgraded Poonawalla Fincorp’s rating by two notches to AA+ largely on account of the improvement in the company’s capital base after the new promoters infused a total of ₹3,900 crore into the company and its mortgage lending subsidiary Poonawalla Housing Finance.
Mumbai: Poonawalla Fincorp, the financial venture promoted by Adar Poonawalla, CEO of Covishield vaccine maker Serum Institute, expects to reduce its cost of funds by at least 100 basis points this fiscal helped by a rating upgrade and better access to bank funds even as it has set itself a target to increase its loan assets by three times in the next four years.
One basis point is 0.01 percentage point.
Managing director Abhay Bhutada said
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Sign in to read the full article
You’ve got this Prime Story as a Free Gift
₹399/month
Monthly
PLAN
Billed Amount ₹399
₹208/month
(Save 49%)
Yearly
PLAN
Billed Amount ₹2,499
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
₹150/month
(Save 63%)
2-Year
PLAN
Billed Amount ₹3,599
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
Already a Member? Sign In now
September Special Offer
Get Flat 20% Off
ON ET PRIME MEMBERSHIP
Get Offer
Why ?
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
Clean experience with
Minimal AdsComment & Engage with ET Prime community
Exclusive invites to Virtual Events with Industry Leaders
A trusted team of Journalists & Analysts who can best filter signal from noise
For all the latest Business News Click Here
For the latest news and updates, follow us on Google News.